Navigation Links
Six Positive Predictions for 2008, from SuperLife World Service
Date:12/19/2007

rovides artistic therapeutics for personal growth and fun. Others make life better through green building, consciousness enhancement, and more.

Featured experts, all at the cutting edge, include leaders in medicine, biotechnology, physics, electronics, psychology, sociology, philosophy, religion, business, the arts, and community development.

SuperLife is an offering of EraNova Institute, a New Jersey think tank directed by Samson.

Samson introduced the concepts of hyper-human skills, hyperjobs, and the hyper-human economy in Futurist Magazine in 2004 and 2005. An expert on mental skills, he has published 10 books and served as consultant to IBM, AT&T, and other leading organizations.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE EraNova/SuperLife
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
3. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
4. Nutrition model stresses positive experience of eating
5. Ultrasound plus mammography finds more cancers, but increases false positives
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
8. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
9. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
10. A low prevalence of H pylori in HIV-positive patients
11. Drug Company-Funded Asthma Drug Studies More Positive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ces of Pay-for-Performance Programs , At a time ...g, this study finds that while such programs may s...ng physician income, they also change the nature o...rses work together. In-depth interviews with 41 fa...ingdom three years after implementation of a new p...
(Date:5/11/2008)...y 11 /PRNewswire/ -- The Myanmar Relief Fund,( htt...private American and,Myanmar citizens that have th...ms bypassing bureaucratic barriers. Teams of docto...ies are being distributed., The Myanmar Relief Fu...citizens with headquarters in California and Yango...
(Date:5/11/2008)...Biotechnology and Biological Sciences Research Cou...o investigate important aspects of human ageing. ...niversity, Dr Lynne Cox and Dr Robert Saunders hav...s can now be used to study the effects ageing has ...l Aging Cell, the researchers demonstrate the valu...
(Date:5/11/2008)... 20). Senior White House Correspondent Richard,Wol... at the presidential,candidate,s leadership and ma...or the coming mud war with John McCain and the Rep...ll be about the big issues because there,are stark...e economy.,They,re also ready for attacks from ano...
Breaking Medicine News(10 mins):Health News:May/June 2008 Annals of Family Medicine tip sheet 2Health News:May/June 2008 Annals of Family Medicine tip sheet 3Health News:May/June 2008 Annals of Family Medicine tip sheet 4Health News:May/June 2008 Annals of Family Medicine tip sheet 5Health News:May/June 2008 Annals of Family Medicine tip sheet 6Health News:Human aging gene found in flies 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 3Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 4Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 5
...t Harvard Nurses' Health study, women who drink fo...loping gallstones than those who do not drink coff...esults. Women are twice as likely to be affected w...en who are overweight or have experienced rapid we...
...urvey of more than 149,000 Americans including 23,...ity showed that 25% of adults with disabilities, c... a risk of obesity.// Obesity was defined as havin...he study also highlighted that adults with lower l...
...study researchers have observed that there is evid...l, is the best way forward in peripheral arterial ...r over will be affected by peripheral arterial dis...ue, in the leg arteries leads to pain, aching, and...
...rs it is observed that a drug already being used t...ective male contraceptive. Researchers hypothesize...en approved in Europe to treat Gaucher's disease, ...ffects the metabolism of sugar-fat compounds essen...
Other Medicine News:
(Date:5/8/2008)...oan-Kettering Cancer Center Investigators to Asses...an Cancer Patients -, BRISBANE, Calif., May 8 /PR...the expansion of Phase 2 clinical trial programs f...his is the third major clinical trial,of BSI-201 t...ding on,on-going trials in breast and brain cancer...
(Date:5/8/2008)...y 8 /- Go Healthy (Pink She...nical trials with Cholesterade (R),in three medica... of 200,patients in 6 centers around the country. ... at The Methodist Hospital in the Texas Medical Ce... was formerly the Team,Physician for the Houston A...
(Date:5/7/2008)...May 7 /- Arena Pharmaceutic...isho Pharmaceutical Co., Ltd.,initiated a Phase 1 ...cused,partnership with Arena to develop compounds ... is a novel oral compound intended for the treatme...y happy to see our long-standing partner, Taisho,...
(Date:5/7/2008)... May 7 /- Shire plc (LSE: S...ceutical company, presented,today at a major scien...ial,results of INTUNIV, a selective alpha-2A-agoni... medication, which is being evaluated for the,trea...tivity Disorder,(ADHD). The data demonstrated that...
Breaking Medicine Technology:BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Go Healthy Initiates Additional Clinical Tests on Cholesterade 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6HSA Plans Gain Popularity as Premium Costs Rise 2129 1HSA Plans Gain Popularity as Premium Costs Rise 2129 2Ikaria Founding Scientist Named 2007 MacArthur Fellow 867 1Ikaria Founding Scientist Named 2007 MacArthur Fellow 867 2Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC 2123 1Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC 2123 2Mustafa alAbsi Ph D and national team awarded major NIH grant 582 1Mustafa alAbsi Ph D and national team awarded major NIH grant 582 2
...Newswire-FirstCall/ -- Sosei Group,Corporation , a...ccessful completion of a study of its fentanyl sub...e treatment of cancer,breakthrough pain. , This wa...bel,single dose, cross-over, randomised study of ... citrate lozenge) and versus fentanyl,citrate inje...
...007 /PRNewswire-FirstCall/ -- Auxilium,Pharmaceuti...ovements in symptoms of decreased libido, energy l...onadal men after switching,brands of testosterone ... increased significantly in patients who switched ...owing suboptimal,response to Solvay S.A.,s Androge...
Other Medicine Technology:Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
The Labcyte Echo 550 compound reformatter performs direct microplate-to-microplate transfers of droplets down to 5 nL using a new "touchless" transfer technology based on focused acoustic energy. Mon
Wellpro 384, compatible with hood installations. An automated liquid handling system for 384-well plates, that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also
Precise, nanoliter-volume liquid handling capability allows you to accurately dispense volumes as small as 5 nanoliters. Precision robotics and flexible software ensure accurate, repeatable X/Y motio
... series of robotic workstations is designed for la...e ideal automation platform for routine sample pre...procedures, improving throughput, process consiste...rep software allows you to control the robotic and...
Medicine Products: